Cardiac wall tension relief device and method

Details Cardiac wall tension relief device and method Cardiac wall tension relief device and method

2004-10-05

2009-11-17

Gilbert, Samuel G (Department: 3735)

Surgery

Internal organ support or sling

Reexamination Certificate

active

07618364

ABSTRACT:
Method and apparatus are disclosed for treating congestive heart failure by administering a fibrosis-inducing agent to an epicardial surface of the heart in an amount selected to induce the formation of fibrosis on the epicardial surface. The fibrosis-inducing agent may be a drug, metal, abrasive or an electrical stimulation on the epicardial surface.

REFERENCES:
patent: 5702343 (1997-12-01), Alferness
patent: 6059715 (2000-05-01), Schweich et al.
patent: 6077214 (2000-06-01), Mortier et al.
patent: 6123662 (2000-09-01), Alferness et al.
patent: 6425856 (2002-07-01), Shapland et al.
patent: 6463332 (2002-10-01), Aldrich
patent: 6482146 (2002-11-01), Alferness et al.
patent: 6508756 (2003-01-01), Kung et al.
patent: 6572533 (2003-06-01), Shapland et al.
patent: 6682476 (2004-01-01), Alferness et al.
patent: 6692458 (2004-02-01), Forman et al.
patent: 6730016 (2004-05-01), Cox et al.
patent: 7174896 (2007-02-01), Lau
patent: 2002/0169360 (2002-11-01), Taylor et al.
patent: 2003/0229265 (2003-12-01), Girard et al.
patent: 2004/0138521 (2004-07-01), Grabek et al.
patent: 2005/0165466 (2005-07-01), Morris et al.
patent: 2271829 (1990-11-01), None
Ludwick, “Schlerosing Agents,” Jul. 25, 2002, http://www.bcm.edu/oto/grand/07-25-02.htm, 11 pages, dated printed Oct. 27, 2004.
Nishi, et al., “Hypoxia-Inducible Factor 1 Mediates Upregulation of Telomerase (hTERT),”Molecular and Cellular Biology, pp. 6076-6083 (Jul. 2004).
Minatoguchi, et al., “Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony—Stimulating Factor Treatment,”Circulation, pp. 2572-2580 (Jun. 2004).
Ohtsuka, et al., “Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovasculatrization,”FASEB, vol. 18, pp. 851-853 (May 2004).
Zou, et al., “Leukemia Inhibitory Factor Enhances Survival of Cardiomyocytes and Induces Regeneration of Myocardium After Myocardial Infarction,”Circulation, pp. 748-753 (Aug. 2003).
Nadal-Ginard, et al., “Myocyte Death, Growth, and Regeneration in Cardiac Hypertrophy and Failure,”Circulation, pp. 139-150 (Feb. 2003).
Kajstura, et al., “Myocyte proliferation in end-stage cardiac failure in humans,”Proc. Natl. Acad. Sci. USA, vol. 95, pp. 8801-8805 (Jul. 1998).
Liu, et al., “A possible role of initial cell death due to mechanical stretch in the regulation of subsequent cell proliferation in experimental vein grafts,”Biomechan. Model Mechanobiol., pp. 17-27 (2002).
Brietzke, S. et al., “Injection snoreplasty: How to treat snoring without all the pain and expense,”Otolaryngol Head Neck Surg., vol. 124, pp. 503-510 (May 2001).

Affiliated with

Also associated with

Rating

Cardiac wall tension relief device and method does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cardiac wall tension relief device and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiac wall tension relief device and method will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4072271